TATACHEM.NS Profit & Loss
Tata Chemicals Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 9 years on file
(FY2017-18 to FY2025-26)
· fetched 2026-08-24 00:32
| Line item | FY2017-18 | FY2018-19 | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹103.45 Bn | ₹112.96 Bn | ₹103.57 Bn | ₹102.00 Bn | ₹126.22 Bn | ₹167.89 Bn | ₹154.21 Bn | ₹148.87 Bn | ₹145.84 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | ₹144.32 Bn | ₹119.21 Bn | ₹103.57 Bn | ₹102.00 Bn | ₹126.22 Bn | ₹167.89 Bn | ₹154.21 Bn | ₹148.87 Bn | ₹145.84 Bn | SegmentRevenueFromOperations |
| Other Income | ₹1.59 Bn | ₹4.12 Bn | ₹3.11 Bn | ₹2.34 Bn | ₹2.56 Bn | ₹2.18 Bn | ₹2.86 Bn | ₹2.25 Bn | ₹3.16 Bn | OtherIncome |
| Total Income | ₹105.05 Bn | ₹117.08 Bn | ₹106.68 Bn | ₹104.34 Bn | ₹128.78 Bn | ₹170.07 Bn | ₹157.07 Bn | ₹151.12 Bn | ₹149.00 Bn | Income |
| Cost of Materials Consumed | ₹13.91 Bn | ₹18.04 Bn | ₹18.44 Bn | ₹20.81 Bn | ₹24.24 Bn | ₹29.47 Bn | ₹27.10 Bn | ₹25.60 Bn | ₹29.58 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹4.69 Bn | ₹4.39 Bn | ₹2.52 Bn | ₹3.23 Bn | ₹3.36 Bn | ₹3.64 Bn | ₹2.32 Bn | ₹2.90 Bn | ₹3.05 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-1.04 Bn | ₹-1.05 Bn | ₹-1.28 Bn | ₹-0.07 Bn | ₹-1.23 Bn | ₹-0.28 Bn | ₹-2.41 Bn | ₹0.28 Bn | ₹-0.79 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹12.70 Bn | ₹13.52 Bn | ₹13.75 Bn | ₹14.00 Bn | ₹15.40 Bn | ₹16.91 Bn | ₹18.60 Bn | ₹19.89 Bn | ₹20.60 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹3.26 Bn | ₹3.63 Bn | ₹3.42 Bn | ₹3.67 Bn | ₹3.03 Bn | ₹4.06 Bn | ₹5.30 Bn | ₹5.63 Bn | ₹5.90 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹5.18 Bn | ₹5.71 Bn | ₹6.66 Bn | ₹7.59 Bn | ₹8.06 Bn | ₹8.92 Bn | ₹9.80 Bn | ₹11.23 Bn | ₹12.01 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹51.29 Bn | ₹57.12 Bn | ₹50.64 Bn | ₹49.02 Bn | ₹61.40 Bn | ₹79.93 Bn | ₹80.13 Bn | ₹80.67 Bn | ₹75.35 Bn | OtherExpenses |
| Total Expenses | ₹89.98 Bn | ₹101.36 Bn | ₹94.16 Bn | ₹98.26 Bn | ₹114.26 Bn | ₹142.65 Bn | ₹140.84 Bn | ₹146.20 Bn | ₹145.70 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹15.07 Bn | ₹15.72 Bn | ₹12.52 Bn | ₹6.08 Bn | ₹14.52 Bn | ₹27.42 Bn | ₹16.23 Bn | ₹4.92 Bn | ₹3.30 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.64 Bn | ₹0.70 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹-0.11 Bn | ₹0.00 Bn | ₹-8.61 Bn | ₹-1.25 Bn | ₹-19.56 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹15.71 Bn | ₹16.43 Bn | ₹12.52 Bn | ₹6.08 Bn | ₹14.41 Bn | ₹27.42 Bn | ₹7.62 Bn | ₹3.67 Bn | ₹-16.26 Bn | ProfitBeforeTax |
| Tax Expense | ₹0.60 Bn | ₹3.47 Bn | ₹2.20 Bn | ₹1.98 Bn | ₹2.66 Bn | ₹2.88 Bn | ₹3.81 Bn | ₹1.67 Bn | ₹2.56 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹27.02 Bn | ₹13.87 Bn | ₹72.28 Bn | ₹4.36 Bn | ₹14.05 Bn | ₹24.34 Bn | ₹4.35 Bn | ₹3.87 Bn | ₹-17.15 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹24.33 Bn | ₹11.56 Bn | ₹70.06 Bn | ₹2.56 Bn | ₹12.58 Bn | ₹23.17 Bn | ₹2.68 Bn | ₹2.35 Bn | ₹-18.96 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹95.51 | ₹45.38 | ₹275.02 | ₹10.06 | ₹49.37 | ₹90.95 | ₹10.52 | ₹9.23 | ₹-74.42 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹95.51 | ₹45.38 | ₹275.02 | ₹10.06 | ₹49.37 | ₹90.95 | ₹10.52 | ₹9.23 | ₹-74.42 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from TATACHEM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Chemicals companies compare).